Aspiriant LLC’s State Street Energy Select Sector SPDR ETF XLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,496
Closed -$315K 215
2019
Q4
$315K Sell
10,496
-676
-6% -$20K 0.03% 167
2019
Q3
$330K Buy
11,172
+306
+3% +$9.26K 0.03% 170
2019
Q2
$347K Sell
10,866
-730
-6% -$23.4K 0.03% 170
2019
Q1
$383K Sell
11,596
-6,000
-34% -$193K 0.03% 164
2018
Q4
$504K Sell
17,596
-4,920
-22% -$165K 0.04% 142
2018
Q3
$851K Sell
22,516
-478
-2% -$17.9K 0.07% 116
2018
Q2
$873K Buy
22,994
+6,158
+37% +$229K 0.07% 116
2018
Q1
$567K Buy
+16,836
New +$596K 0.05% 145
2017
Q4
Sell
-17,722
Closed -$607K 191
2017
Q3
$607K Sell
17,722
-13,690
-44% -$445K 0.05% 130
2017
Q2
$1.02M Buy
31,412
+3,930
+14% +$132K 0.09% 109
2017
Q1
$960K Buy
27,482
+15,698
+133% +$567K 0.08% 120
2016
Q4
$444K Hold
11,784
0.04% 143
2016
Q3
$416K Sell
11,784
-71,642
-86% -$2.45M 0.04% 148
2016
Q2
$3.06M Buy
83,426
+32,338
+63% +$1.07M 0.29% 61
2016
Q1
$1.58M Buy
+51,088
New +$1.48M 0.15% 81

Other funds holding XLE

Aspiriant LLC's XLE Position: Q1 2020 in Review

Aspiriant LLC sold out of State Street Energy Select Sector SPDR ETF (XLE) in Q1 2020, closing a stake of 10,496 shares — an estimated $315K sold.

Aspiriant LLC first reported a position in XLE in Q1 2016 and held it in 15 quarters. The position peaked at $3.06M in Q2 2016. 747 funds tracked by Wall St. Rank hold XLE as of Q1 2020.

  • Aspiriant LLC reported no remaining State Street Energy Select Sector SPDR ETF position as of Q1 2020 after selling out during the quarter.
  • Aspiriant LLC sold 10,496 State Street Energy Select Sector SPDR ETF shares in Q1 2020, an estimated $315K.
  • Aspiriant LLC first reported a position in State Street Energy Select Sector SPDR ETF in Q1 2016 and held it in 15 quarters.
  • Aspiriant LLC's State Street Energy Select Sector SPDR ETF position peaked at $3.06M in Q2 2016.
  • 747 funds tracked by Wall St. Rank held State Street Energy Select Sector SPDR ETF as of Q1 2020.

Based on Aspiriant LLC's 13F filing for Q1 2020, filed 5 May 2020.